|  |  |  |   | 
| 1-PP | Quality of diagnosis and lab monitoring of people with hemophilia and other bleeding disorders across the continents: WFH IEQAS programme results over the last 8 years | Silmara Montalvao |  Received | 
|  | |||
| 3-PP | The genetic landscape of factor 8 in people with Haemophilia A from central South Africa | Jean Kloppers |  Received | 
|  | |||
| 4-PP | Inhibitor screening of hemophilia A patients at HTC at PIMS Pakistan | Farwa Sijjeel |  Received | 
|  | |||
| 5-PO | Genotype-phenotype analyses of Iranian patients with and without hemophilia B Leyden: A single-center study | Shadi Tabibian |  Received | 
|  | |||
| 8-PO | Innovation in Education: Interactive Model of Blood Clotting Cascade and Hemophilia | Ahmed Saeed |  Received | 
|  | |||
| 9-PP | WFH Programs in Eastern Mediterranean Region | Ellia Tootoonchian |  Received | 
|  | |||
| 11-PP | World Federation of Hemophilia (WFH) Path to Access to Care and Treatment (PACT) Program Advocacy Academy Global Impact | Salome Mekhuzla |  Received | 
|  | |||
| 12-PP | 50 years of history: key milestones in access to better treatment in Uruguay | Juan Andrés Pereira De Souza |  Received | 
|  | |||
| 14-PO | Generational exchange in Uruguay: lessons learnt and the key to success | Juan Andrés Pereira De Souza |  Received | 
|  | |||
| 15-PO | Women Now: Identify and register hemophilia carriers when no diagnosis is available | Isabel Sorondo |  Received | 
|  | |||
| 18-PP | Teaching Multidisciplinary Health Care Providers on Hemophilia and other Rare bleeding disorders in Kenya | IRENE KHAEMBA |  Received | 
|  | |||
| 21-PP | Prenatal testing versus Prophylaxis with newer drugs in severe haemophilia patients in India: cost assessment. | Rucha Patil |  Received | 
|  | |||
| 22-PP | Navigating Surgical Challenges: Best Practices for Managing Hemophilia Patients in the Operating Room | Prisha Nankana |  Received | 
|  | |||
| 23-PP | Overview of adults and children with hemophilia in Hemophilia Treatment Center of Sfax | Maha Charfi |  Received | 
|  | |||
| 25-PP | A proposal to measure the gross motor development of infants with haemophilia | Dimitrios Syrengelas |  Received | 
|  | |||
| 26-PP | Announcing the diagnosis of a benign chronic disease the case of hemophilia : A Moroccan Case Study | Mohamed El Khorassani |  Received | 
|  | |||
| 27-PO | Is there a silver lining in Glanzman Thrombasthenia after puberty? | Ahmad Tarawah |  Received | 
|  | |||
| 28-PO | FVIII Half-Life Products: a Real-World Experience | Ezio zanon |  Received | 
|  | |||
| 29-PP | Tunisian experience Center with Emicizumab | Ons Ghali |  Received | 
|  | |||
| 31-PP | Hematuria in Paediatric Hemophilia A Local Malaysian Experience (Main Centre) | Liana Yusof |  Received | 
|  | |||
| 33-PO | Ulcerative colitis in two brothers with severe haemophilia A | Monika Biernat |  Received | 
|  | |||
| 39-PO | Bilateral Haemophilic Pseudotumors in Both Thighs with Haemophilic Knee Arthropathy: A Twisted Parallelism | Pranav Keswani |  Received | 
|  | |||
| 40-PO | Complex Primary Total Knee Arthroplasty in Haemophilic Arthropathy with Extraarticular Deformity | Pranav Keswani |  Received | 
|  | |||
| 42-PO | Acquired hemophilia A Post-COVID-19 Vaccination successfully treated with low dose of rituximab | wafa chenbah |  Received | 
|  | |||
| 43-PP | The A-MOVE study easily explained: the value of regular joint assessments in individuals with haemophilia | Markus Fusser |  Received | 
|  | |||
| 44-PP | Long-term outcomes of prophylaxis with efanesoctocog alfa in adults and adolescents previously treated on demand: second interim analysis of XTEND-ed | Helena Palmborg |  Received | 
|  | |||
| 45-PP | Plain language summary of two-year results of weekly efanesoctocog alfa treatment in children with severe haemophilia A: Interim analysis of the XTEND-ed phase 3 study | Graham Neill |  Received | 
|  | |||
| 46-PP | Plain language summary: Efanesoctocog alfa treatment outcomes over 3 years in adults & adolescents with severe haemophilia A in the long-term XTEND-ed study | Elena Santagostino |  Received | 
|  | |||
| 47-PP | A Natural History Study of Bleeding Symptoms and Treatment Outcomes in Patients with Glanzmann Thrombasthenia The Pakistan Site Experience | Shelby Domino |  Received | 
|  | |||
| 49-PP | Comparison of the haemorrhagic phenotype between female and male patients affected by Autosomal Inherited Bleeding Disorders in a single-centre cohort | Tiziano Martini |  Received | 
|  | |||
| 50-PP | A prospective, observational longitudinal study of functional outcome of radionuclide synoviorthesis in haemophilic arthropathy | Pranav Keswani |  Received | 
|  | |||
| 54-PP | The need to improve diagnostic capacity in low- middle-income countries: lessons from the WBDR and Nigeria as a case study | Ellia Tootoonchian |  Received | 
|  | |||
| 55-PP | Aziza Othmana HTC experience with hemophilia and World Bleeding Disorder Registry (WBDR) | Emna Gouider |  Received | 
|  | |||
| 56-PP | Hemophilia life stages and changes global survey for people with hemophilia, caregivers and hematologists: survey design and demographics | Tom Martin |  Received | 
|  | |||
| 57-PP | Innovative Approaches to Managing Hemophilia in Economically Disadvantaged Patients: Lessons from a Resource-Limited Setting | Vishakha Dongare |  Received | 
|  | |||
| 58-PP | Launch of the Economics and Patient Outcomes in China in Haemophilia (EPOCH) Study Online Platform and First Patient Enrolled | Brian OMahony |  Received | 
|  | |||
| 59-PP | Real-life demographic landscape of congenital hemophilia in Romania | Simina Pirv |  Received | 
|  | |||
| 60-PP | Knowledge Transfer Program in NMOs. Statistical analysis of our reality. | Antonio Gomez Cavallini |  Received | 
|  | |||
| 61-PO | WFH Initiative on Gene Editing for Hemophilia | Mayss Naccache |  Received | 
|  | |||
| 62-PO | Comprehensive care planning for commercial gene therapy patients: Psychosocial, physical and medical considerations | Mosi Williams |  Received | 
|  | |||
| 63-PP | HEMCOSTING : A Customizable Cost-Effectiveness Microsimulation Model to Compare the Costs and Effects of Several Hemophilia A and B Treatment Strategies in Any Context | Nancy Bolous |  Received | 
|  | |||
| 64-PP | A Comprehensive Societal Costing Checklist to Guide Health Economic Analyses in Haemophilia | Nancy Bolous |  Received | 
|  | |||
| 65-PP | Is haemophilia classification restricting clinicians from providing optimal care for joint health in non-severe haemophilia? A case study series. | Alfie McBrien |  Received | 
|  | |||
| 66-PP | Knowledge, Attitudes, and Practices Regarding Home Based Treatment of Hemophilia Among Healthcare Professionals in Morocco | Fatima Zahra Ben Fouila |  Received | 
|  | |||
| 69-PP | HEAD-US and HJHS in Comparison with MRI for the Evaluation of Joint Health in Children with Haemophilia A: a Single Centre Experience | Athina Dettoraki |  Received | 
|  | |||
| 70-PP | The value of ultrasound in detecting subclinical abnormalities in joints of patients with hemophilia | Xinjuan Guo |  Received | 
|  | |||
| 72-PP | Clinical Application Value of the Chinese Expert Consensus on Ultrasound Assessment of Hemophilic Arthropathy | Jun Li |  Received | 
|  | |||
| 73-PP | Dual Immune Regulation: Exploring the Role of Regulatory T Cells and Regulatory B Cells in Modulating Inhibitor Development in people with Hemophilia A | Rashmi Kushwaha |  Received | 
|  | |||
| 76-PP | High responding inhibitors in patient with hemophilia: A single center experience in south Tunisia | Maha Charfi |  Received | 
|  | |||
| 80-PP | Thromboelastometry Clotting Profiles and Plasma Emicizumab Levels in Hemophilia A Patients on Low-Dose Emicizumab Prophylaxis for two to four years | Rucha Patil |  Received | 
|  | |||
| 81-PP | Usability evaluation of a novel point of care platform to simultaneously test FVIII activity and Thrombin generation | Aernoud Bavinck |  Received | 
|  | |||
| 82-PP | Turoctocog alpha Pegol in patients with Hemophilia A undergoing surgical procedures: A single center experience from North India | Akshay Middinti |  Received | 
|  | |||
| 83-PP | Cost-effectiveness and outcomes of radioactive synovectomy versus arthroscopy in hemophilic synovitis: a Brazilian perspective | Mariana Battazza |  Received | 
|  | |||
| 84-PP | The evaluation of sarcopenia in people with hemophilia over 40 years of age in Japan. | Kumiko Ono |  Received | 
|  | |||
| 85-PP | TKA in PwH at a Tertiary Care Centre- An experience with 112 patients with a medium term follow-up | Shubhranshu MOHANTY |  Received | 
|  | |||
| 86-PP | Total Hip replacement 50 years of experience in a single center | Maria Landro |  Received | 
|  | |||
| 87-PP | Joint Prosthetic Surgery in Patients with Hemophilia A: clinical-functional outcomes and quality of life | ezio zanon |  Received | 
|  | |||
| 88-PP | Extended tibial tuberosity osteotomy to facilitate implant removal in difficult knee revisions arthroplasty. Our experience with haemophilic patients | Dimitrios Kalatzis |  Received | 
|  | |||
| 91-PP | Postoperative outcomes of total knee arthroplasty in patients with hemophilic knee arthropathy a prospective study | Janie Barry |  Received | 
|  | |||
| 92-PP | Musculoskeletal complications in patients with hemophilia : A single-center experience | Maha Charfi |  Received | 
|  | |||
| 93-PO | Heterotopic ossification in Haemophilia: an 18-year single-centre case series | Adam Hussain |  Received | 
|  | |||
| 94-PP | Treatment of orthopedic complications of hemophilia in Azerbaijan | Mehpara Kazimova |  Received | 
|  | |||
| 95-PO | Major bleeding after Total Knee Replacement in PWH. How to avoid it | Maria Landro |  Received | 
|  | |||
| 96-PO | Efficacy of Treatment Modalities in Hemophilia Patients with Joint Pain: A Retrospective Analysis | Farwa Sijjeel |  Received | 
|  | |||
| 98-PP | Management of Perioperative Hemostasis in two patients with severe Hemophilia A with Inhibitors on Prophylaxis with Emicizumab using Global Hemostasis Assays | Gisela Barros Garcia |  Received | 
|  | |||
| 99-PP | Weekly Nordic Walking training improves joint health at one year in patients with haemophilia | Elena Anna Boccalandro |  Received | 
|  | |||
| 101-PP | Association between arthropathy and peripheral neuropathies in adults with hemophilia | Aidee Gibraltar Conde |  Received | 
|  | |||
| 102-PP | Conditioned pain modulation in patients with hemophilic arthropathy of the lower limbs. Multicentre cross-sectional cohort study. | Rubén Cuesta-Barriuso |  Received | 
|  | |||
| 103-PP | Finding the Right Flow: Acute Responses to Autoregulated vs. Non-Autoregulated Blood Flow Restriction in Elbow Rehabilitation for Hemophilia | Joaquín Calatayud |  Received | 
|  | |||
| 104-PP | Neuromotor reprogramming in people with Hemophilia (Allyane Method) | Mauro Dyntino |  Received | 
|  | |||
| 105-PP | Blood flow restriction in patients with hemophilic arthropathy. A pilot safety study | Rubén Cuesta-Barriuso |  Received | 
|  | |||
| 106-PP | Expanding HJHS: a full body assessment may provide more information on musculoskeletal health | Elena Anna Boccalandro |  Received | 
|  | |||
| 107-PP | Spinal Stenosis: The need to adapt physiotherapy approaches to older persons with haemophilia | Mark Mcgowan |  Received | 
|  | |||
| 108-PP | Creating physiotherapy guidelines for the management of iliopsoas haematomas in people with bleeding disorders | Richard Davis |  Received | 
|  | |||
| 109-PP | Comparative Efficacy of Guided Physical Therapy and Home-Based Care on Joint Health and Physical Function in Patients with Mild Hemophilia | Sandeep Kumar |  Received | 
|  | |||
| 110-PP | Overview Joint Health Status in haemophilia patients: a single Centre experience in Argentina | Estanislao Vera Santos |  Received | 
|  | |||
| 111-PP | Intra-articular injection of platelet-rich plasma (PRP) in addition to hyaluronic acid (HA) in the treatment of hemophilic artropathy | Cecilia Gallardo |  Received | 
|  | |||
| 112-PP | Comprehensive Rehabilitation Plan (RP) for Haemophilia Patients: Enhancing Joint Mobility, Quality of Life and Long-Term Stability | Martin Kaal |  Received | 
|  | |||
| 113-PO | Clinical Impact Of Recurrent Bleeding Episode On Joint Health And Functional Independence In Factor Vll Deficiency: A Retrospective Cause Report | Adithya TS |  Received | 
|  | |||
| 115-PO | Physiotherapy clinic: a single-center experience in musculoskeletal health management for patients with haemophilia | Elena Anna Boccalandro |  Received | 
|  | |||
| 116-PO | IMPACT OF PHYSIOTHERAPY ON HEMOPHILIC JOINT HEALTH SCORE | Manisha Syal |  Received | 
|  | |||
| 117-PO | EFFECT OF TAILOR-MADE EXERCISE PROTOCOL ON JOINT HEALTH AND PHYSICAL ACTIVITY IN CHILDREN WITH HEMOPHILIA | Smati Sambyal |  Received | 
|  | |||
| 118-PP | Standard dose Vs Low dose Emicizumab Prophylaxis in patients with Hemophilia A with Inhibitors - Single centre, Prospective Observational study | Shailendra Verma |  Received | 
|  | |||
| 119-PP | REAL-WORLD EXPERIENCE OF PROPHYLAXIS WITH EMICIZUMAB IN CHILDREN WITH HAEMOPHILIA A: A SINGLE CENTRE EXPERIENCE | Athina Dettoraki |  Received | 
|  | |||
| 120-PP | Nonacog beta pegol prophylaxis in pediatric patients with severe Hemophilia B: A single centre experience from North India | Shailendra Verma |  Received | 
|  | |||
| 122-PO | Denial of Prophylaxis in early adulthood leads to increased bleed rates and college absenteeism in a resource limited setting. | Rema Ganapathi |  Received | 
|  | |||
| 123-PO | Prophylactic treatment of hemophilia A patients in Azerbaijan | Gunel Alizade |  Received | 
|  | |||
| 124-PP | A pilot study investigating specific types of sexual difficulties in Tunisian Hemophiliacs. | wafa chenbah |  Received | 
|  | |||
| 125-PP | Degree of burden in primary caregivers of patients with hemophilia in Mexico | Ezequiel Martínez Martínez |  Received | 
|  | |||
| 126-PP | PACT Project: Empowering Women and Girls with Bleeding Disorders by Multidisciplinary Awareness and Psychosocial Support | Hina Fatima |  Received | 
|  | |||
| 127-PP | Walk and Talk Group: A supportive MDT community-based initiative for adults within the Bleeding Disorders Network Wales, UK | Kathleen Moore |  Received | 
|  | |||
| 128-PP | Psychological well-being of informal caregivers of people with coagulopathies in Mexico | Ezequiel Martínez Martínez |  Received | 
|  | |||
| 130-PP | A multidisciplinary nonmedical management approach to improve the quality of life of hemophilia, beyond medical treatment | Fariba Shokri |  Received | 
|  | |||
| 131-PP | Intra-articular injection of biological factors for the management of hemophilic arthropathy. | Dimitrios Kalatzis |  Received | 
|  | |||
| 132-PP | Quality of life of patients with hemophilia in Madagascar | Lindsay Kouatie Njonger |  Received | 
|  | |||
| 133-PP | Development of the Hemophilia Life Interference Questionnaire (HLIQ): A tool to evaluate the impact of hemophilia B and its treatment on patient lives | Sheena Thakkar |  Received | 
|  | |||
| 135-PP | Achieving Zero Annual Bleed Rate and Assessing Joint Health in Children with Hemophilia on Emicizumab Prophylaxis: Insights from a Low- and Middle-Income Country | Shigy Francis |  Received | 
|  | |||
| 136-PP | Successful Liver Transplantation in a Patient with Hemophilia A and Inhibitors: A Case Report | Abdulrahman Nasiri |  Received | 
|  | |||
| 137-PP | Treatment adherence, satisfaction and quality of life in adult patients with hemophilia A: A real-world survey of physicians and patients in the Kingdom of Saudi Arabia | Sheena Thakkar |  Received | 
|  | |||
| 138-PP | Prevalence of Depression in Adults with Hemophilia Using the Patient Health Questionnaire-9 (PHQ-9) | wafa chenbah |  Received | 
|  | |||
| 139-PP | Impact of Home Education and Self-Management Strategies on Quality-of-Life in Patients with Hemophilia: Preliminary Report of a Systematic Review and Meta-Analysis of Randomized Controlled Trials | Jose Santacruz-Arias |  Received | 
|  | |||
| 140-PO | Sports participation and psychosocial condition of patients with haemophilia in Hong Kong | Henry Hon-Wai Lam |  Received | 
|  | |||
| 141-PO | Assessment of Quality of Life in Tunisian Hemophilia Patients Using the EQ-5D Questionnaire | wafa chenbah |  Received | 
|  | |||
| 142-PO | Impact of Bernard-Soulier Syndrome on Patient Quality of life::A comprehensive Assessment using EQ-5D-5LTool | AJAI THOMAS |  Received | 
|  | |||
| 144-PP | Real-world effectiveness and safety of damoctocog alfa pegol in patients with a history of inhibitors: Fifth interim analysis of the HEM-POWR study | Amanda Ward |  Received | 
|  | |||
| 145-PP | Fifth interim analysis of the HEM-POWR study: A post hoc analysis of real-world effectiveness and safety of damoctocog alfa pegol in patients with mild and moderate haemophilia A | Amanda Ward |  Received | 
|  | |||
| 146-PP | Real-world effectiveness and safety of damoctocog alfa pegol in adolescent and older patients with haemophilia A in the fifth interim analysis of the HEM-POWR study | Amanda Ward |  Received | 
|  | |||
| 147-PP | The role of global hemostasis testing in the diagnosis and management of rare bleeding disorders: A six-year experience from a single tertiary care center in Kerala | Bitty Kurian |  Received | 
|  | |||
| 148-PP | Characteristics of Factor XIII Deficiency in Childhood: A Retrospective Study in Medina, Saudi Arabia | Noura Alsaid |  Received | 
|  | |||
| 149-PP | PATIENTS WITH PLATELET DISORDERS IN TUNISIA: WHERE ARE WE? | Meriem Achour |  Received | 
|  | |||
| 150-PP | Revolutionizing Rare Bleeding Disorder Management with Prophylactic Factor Replacement: Experience from a Tertiary care Centre in North India | Prisha Nankana |  Received | 
|  | |||
| 151-PP | Clinical phenotype, Thromboembolic complication and quality of life in a cohort of patients with afibrinogenemia | Meriem Bensadok |  Received | 
|  | |||
| 152-PP | Clinical spectrum and treatment outcomes of Rare Bleeding Disorders in females: A two-center experience in North Pakistan | muhammad usman |  Received | 
|  | |||
| 155-PP | Epidemiological and clinical-biological aspects of factor XIII deficiency in southern Tunisia | Imen Frikha |  Received | 
|  | |||
| 158-PO | Unveiling the Spectrum: Rare Bleeding Disorders in Eastern Uttar Pradesh, India | Rashmi Kushwaha |  Received | 
|  | |||
| 161-PO | MUSCULOSKELETAL LESIONS IN PATIENTS WITH FVII DEFICIENCY: EXPERIENCE IN VENEZUELA | Apsara Boadas |  Received | 
|  | |||
| 162-PO | Perioperative management for patients with congenital factor VII deficiency | IMEN Ben amor |  Received | 
|  | |||
| 165-PP | Quality of care for Hemophilia in Colombia: Ten Years of the Colombian Hemophilia Registry | Adriana Linares |  Received | 
|  | |||
| 166-PP | Effectiveness of post physiotherapy Gym protocol in enhancing fitness, psycho social well being and self confidence in young adult patients with hemophilia: a pilot Study | Geeta Suri Sharma |  Received | 
|  | |||
| 168-PP | Experience in treatment patients with severe hemophilia A who receving emicizumab during musculoskeletal surgeries | Tatyana Polyanskaya |  Received | 
|  | |||
| 169-PP | Giant hemophilic pseudotumor of the femur: 2-stages hip disarticulation | Ignacio Soncini |  Received | 
|  | |||
| 170-PO | Patient-Specific Cutting Guides for Total Knee Arthroplasty in Hemophilic Patients: A Surgeon-Driven Solution for Precision and Hemostasis | Salim Fourmas |  Received | 
|  | |||
| 171-PO | Effectiveness and advantages of Turoctocog alfa pegol in the perioperative management of cardiac surgery in a patient with mild hemophilia A | ezio zanon |  Received | 
|  | |||
| 172-PO | Long-term outcome of postoperative Range of Motion in Total Knee Replacement | Carla Daffunchio |  Received | 
|  | |||
| 173-PO | Evolution of Surgical Management and Multidisciplinary Care in Hemophilia: A 15-Year Retrospective Analysis | Salim Fourmas |  Received | 
|  | |||
| 175-PO | Minimally invasive treatment for orthopaedic pathology. 40 years of experience. | Maria Landro |  Received | 
|  | |||
| 176-PO | Detection of ankle joint microbleeds with magnetic resonance imaging in patients with severe haemophilia A on prophylactic treatment | Polona Klavar |  Received | 
|  | |||
| 177-PO | Observational and Phase 1 studies in the Development of Novel Therapies for Von Willebrand Disease: The VELORA Research Program | Jigar Amin |  Received | 
|  | |||
| 178-PO | A Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia: A Trial in Progress | Jigar Amin |  Received | 
|  | |||
| 179-PO | SHINE study design: An interventional, open-label, Phase 4 study investigating changes in synovial hypertrophy in patients with haemophilia A on efanesoctocog alfa prophylaxis | Sana Yaar |  Received | 
|  | |||
| 180-PP | Comprehensive analysis of demographic and clinical profiles in people with von willebrand disease: insights from the WFH World Bleeding Disorders Registry | Donna Coffin |  Received | 
|  | |||
| 181-PP | Von Willebrand disease follow-up and WBDR | Ons Ghali |  Received | 
|  | |||
| 182-PO | Gynecological Bleeding in Women with Congenital Bleeding Disorders: A Comprehensive Cohort from Iran | Shadi Tabibian |  Received | 
|  | |||
| 183-PO | Clinical and Treatment Features of Von Willebrand Deficiency | Huseyin Avni Solgun |  Received | 
|  | |||
| 185-PP | Joint status of Women with bleeding disorders | Carla Daffunchio |  Received | 
|  | |||
| 186-PP | Audit of the Management of Heavy Menstrual Bleeding in Women and Girls with Inherited Bleeding Disorders | Lugain Abdalla |  Received | 
|  | |||
| 187-PP | Development of Women, Girls, and People Who Have or Had the Potential to Menstruate (WGPPM) questionnaire for PROBE study | Dawn Rotellini |  Received | 
|  | |||
| 188-PP | Impact of bleeding on physical activity amongst Women and Girls with Bleeding Disorders in Ireland | Megan Kennedy |  Received | 
|  | |||
| 189-PP | SCREENING OF BLEEDING DISORDERS IN ADOLESCENTS /YOUNG ADULT WOMEN PRESENTING WITH HEAVY MENSTRUAL BLEEDING-A PROSPECTIVE STUDY FROM A SINGLE TERTIARY CARE CENTRE IN KERALA | Bitty Kurian |  Received | 
|  | |||
| 190-PP | Enhancing the Diagnosis of Hemophilia Carriers in Tunisia, Do we need molecular study? È | Eya Drissi |  Received | 
|  | |||
| 191-PP | Hemophilia Foundation of Michigans National Womens Conference: Empowering Change: Transforming Awareness, Advocacy and Care for Women with Hemophilia and Rare Factor Deficiencies | Susan Lerch |  Received | 
|  | |||
| 192-PP | Bleeding manifestations in haemophilia carriers in India | Sharda Shanbhag |  Received | 
|  | |||
| 194-PP | Gynecological and obstetrical hemorrhages in Women with rare bleeding disorders | Nawel Ferroudj |  Received | 
|  | |||
| 195-PP | Gender differences in bleeding disorders in Aziza Othmana HTC from Tunisia | Emna Gouider |  Received | 
|  | |||


 
 
									
				23-25 April 2025 Dubai

 ACTIVE FROM 02/04/2025 TO 25/04/2026
     ACTIVE FROM 02/04/2025 TO 25/04/2026
				|  | Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world.  To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.   |  | ||
|  | ||||
|  | 

